MedTrace Logo

Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer

NCT07584577 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 670

Last updated 2026-05-13

No results posted yet for this study

Summary

Malnutrition is common at the time of diagnosis of esogastric cancers. However, there are no recommendations regarding preoperative nutritional support (type and duration) or on the impact of refeeding on postoperative morbidity and mortality.

Conditions

  • Esophageal Cancer
  • Surgery Indication
  • Malnourished
  • Neoadjuvant Treatment

Interventions

DIETARY_SUPPLEMENT

Enteral or parenteral nutrition

Patients who did not receive enteral or parenteral nutrition during neoadjuvant treatment.

Sponsors & Collaborators

  • French Eso-Gastric Tumors Working Group

    collaborator OTHER

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Caroline GRONNIER, MD, PhD · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-11-01
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07584577 on ClinicalTrials.gov